IDEAYA Biosciences
IDYA
96 hedge funds and large institutions have $489M invested in IDEAYA Biosciences in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 37 reducing their positions, and 16 closing their positions.
686,800% more call options, than puts
Call options by funds: $6.87M | Put options by funds: $1K
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
24% more capital invested
Capital invested by funds: $393M → $489M (+$96.2M)
0.91% more ownership
Funds ownership: 90.79% → 91.7% (+0.91%)
7% less funds holding
Funds holding: 103 → 96 (-7)
22% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 37
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$13.3M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$10M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.01M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$3.15M |
| 5 |
Citigroup
New York
|
+$2.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$4.32M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.08M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.76M |
| 4 |
Two Sigma Investments
New York
|
-$2.58M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.54M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$546K | -48,838 | Closed |
|
|
BG
102
Bellevue Group
Kuesnacht,
Switzerland
| – | -$517K | -46,200 | Closed |
|
103
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$480K | -42,900 | Closed |
|
104
Acadian Asset Management
Boston,
Massachusetts
| – | -$445K | -39,939 | Closed |
|
105
D.E. Shaw & Co
New York
| – | -$275K | -24,590 | Closed |
|
106
Principal Financial Group
Des Moines,
Iowa
| – | -$213K | -18,997 | Closed |
|
|
TI
107
Trexquant Investment
Stamford,
Connecticut
| – | -$203K | -18,133 | Closed |
|
108
HSBC Holdings
London,
United Kingdom
| – | -$133K | -11,787 | Closed |
|
109
ProShare Advisors
Bethesda,
Maryland
| – | -$114K | -10,125 | Closed |
|
|
QT
110
Quantbot Technologies
New York
| – | -$44K | -4,000 | Closed |
|
|
PHK
111
Point72 Hong Kong
Hong Kong
| – | -$38K | -3,376 | Closed |
|
IDYA Hedge Fund Activity: Q2 2022 in Review
96 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q2 2022, worth a combined $489M — up 24% from $393M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of IDYA and 10 opened new positions — a net loss of 6 holders — while 37 trimmed existing stakes and 29 added.
The largest buyer was BVF Inc, adding an estimated $13.3M. The largest seller was State Street, cutting an estimated $4.32M.
- 96 institutional investors held IDEAYA Biosciences (IDYA) as of Q2 2022, down from 103 in Q1 2022.
- Funds reported $489M of IDEAYA Biosciences stock for Q2 2022, up 24% quarter-over-quarter.
- 10 funds opened new IDEAYA Biosciences positions in Q2 2022 and 16 closed out, a net change of -6 holders.
- The largest IDEAYA Biosciences buyer in Q2 2022 was BVF Inc, an estimated $13.3M added.
- The largest IDEAYA Biosciences seller in Q2 2022 was State Street, an estimated $4.32M sold.
Based on aggregated 13F filings for Q2 2022.